Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$465 Buy
308
+251
+440% +$480 ﹤0.01% 2457
2025
Q4
$123 Sell
57
-70
-55% -$239 ﹤0.01% 2518
2025
Q3
$612 Buy
127
+118
+1,311% +$644 ﹤0.01% 2159
2025
Q2
$50 Buy
+9
New +$71 ﹤0.01% 2149

Other funds holding GOCO

Essential Partners's GOCO Position: Q1 2026 in Review

Essential Partners increased its GoHealth (GOCO) stake by 440% in Q1 2026, buying an estimated $480 and bringing the position to 308 shares worth $465. The position accounts for ﹤0.01% of the portfolio, ranked #2457.

Essential Partners first reported a position in GOCO in Q2 2025 and has held it in 4 quarters since. The position peaked at $612 in Q3 2025. 67 funds tracked by Wall St. Rank hold GOCO as of Q1 2026.

  • Essential Partners held 308 shares of GoHealth worth $465 as of Q1 2026.
  • Essential Partners bought 251 GoHealth shares in Q1 2026, an estimated $480.
  • GoHealth made up ﹤0.01% of Essential Partners's portfolio in Q1 2026, its #2457 holding.
  • Essential Partners first reported a position in GoHealth in Q2 2025 and has held it in 4 quarters since.
  • Essential Partners's GoHealth position peaked at $612 in Q3 2025.
  • 67 funds tracked by Wall St. Rank held GoHealth as of Q1 2026.

Based on Essential Partners's 13F filing for Q1 2026, filed 21 May 2026.